Media
Molecular Partners is a privately owned, Zurich-based biotech company engaged in the development of DARPins, a novel class of therapeutic proteins.
We are happy to keep you informed on the latest developments at Molecular Partners. To subscribe to our newsletter, please send an email to newsletter@molecularpartners.com.
For any further inquiries, please feel free to contact us directly, explore our extensive publication list or meet us in person at one of the upcoming events.